Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Italy formalises gene therapy "ban":

This article was originally published in Clinica

Executive Summary

Italy has extended its temporary ban on all forms of gene therapy trials which use retroviral vectors. The Italian health ministry today (October 15 2002) announced that it has passed an urgent order formalising the recent temporary ban (see Clinica No 1028, p 12), until January 31 2003. The order empowers the national healthcare institute (ISS) to approve tests on individual patients, subject to a risk-versus-benefit assessment and the consent of the patient or relevant parties.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel